Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against bluebird bio, Inc. – BLUEGlobeNewsWire • 02/22/21
BLUEBIRD BIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against bluebird bio, Inc.PRNewsWire • 02/19/21
BLUE Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against bluebird bio, Inc. (NASDAQ: BLUE); Lead Plaintiff Deadline is April 13, 2021PRNewsWire • 02/19/21
ROSEN, A TOP RANKED LAW FIRM, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – BLUEGlobeNewsWire • 02/18/21
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 02/18/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 02/18/21
BLUE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmGlobeNewsWire • 02/18/21
BLUE INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.PRNewsWire • 02/18/21
BREAKING ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages bluebird bio, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline - BLUEPRNewsWire • 02/18/21
Shareholder Alert: Robbins LLP Announces That Bluebird Bio, Inc. (BLUE) is Being Sued for Misleading ShareholdersBusiness Wire • 02/17/21
bluebird (BLUE) Down on Suspension of Sickle Cell Disease StudiesZacks Investment Research • 02/17/21
Bluebird Bio Temporarily Suspends Sickle Cell Gene Therapy Studies Following Incidences of Blood CancerBenzinga • 02/16/21
Bluebird Stock Collapses To 7-Year Low On Safety Concern In Gene TherapyInvestors Business Daily • 02/16/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 02/16/21
Bluebird Bio shares slide 34% after company suspends trials of sickle cell disease treatmentMarket Watch • 02/16/21
SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of bluebird bio Investors and Encourages Investors With Significant Losses to Contact the FirmNewsfile Corp • 02/16/21
bluebird bio Announces Temporary Suspension on Phase 1/2 and Phase 3 Studies of LentiGlobin Gene Therapy for Sickle Cell Disease (bb1111)Business Wire • 02/16/21
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against bluebird bio, Inc. (BLUE)GlobeNewsWire • 02/15/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 02/15/21
BREAKING NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages bluebird bio, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline – BLUEBusiness Wire • 02/15/21
Have You Invested In bluebird bio, Inc.? - Class Action Lawsuit Filed On Behalf Of BLUE Investors – Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.GlobeNewsWire • 02/15/21
BLUEBIRD BIO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against bluebird bio, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 02/13/21
Pomerantz Law Firm Announces the Filing of a Class Action against bluebird bio, Inc. and Certain Officers - BLUEPRNewsWire • 02/12/21